A detailed history of Aqr Capital Management LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 303,253 shares of AMRX stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
303,253
Previous 435,082 30.3%
Holding current value
$2.54 Million
Previous $2.76 Million 8.65%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.42 - $8.83 $846,342 - $1.16 Million
-131,829 Reduced 30.3%
303,253 $2.52 Million
Q2 2024

Aug 14, 2024

SELL
$5.36 - $7.11 $1.72 Million - $2.28 Million
-321,305 Reduced 42.48%
435,082 $2.76 Million
Q1 2024

May 15, 2024

SELL
$5.24 - $6.34 $379,176 - $458,775
-72,362 Reduced 8.73%
756,387 $4.58 Million
Q4 2023

Feb 14, 2024

SELL
$3.36 - $6.21 $372,613 - $688,670
-110,897 Reduced 11.8%
828,749 $5.03 Million
Q3 2023

Nov 14, 2023

SELL
$2.76 - $4.59 $3.36 Million - $5.58 Million
-1,216,596 Reduced 56.42%
939,646 $3.97 Million
Q2 2023

Aug 14, 2023

SELL
$1.33 - $3.1 $1.14 Million - $2.65 Million
-854,660 Reduced 28.39%
2,156,242 $6.68 Million
Q1 2023

May 15, 2023

BUY
$1.27 - $2.7 $1.11 Million - $2.36 Million
874,650 Added 40.94%
3,010,902 $4.19 Million
Q4 2022

Feb 14, 2023

BUY
$1.96 - $2.61 $2.28 Million - $3.04 Million
1,164,091 Added 119.74%
2,136,252 $4.25 Million
Q3 2022

Nov 14, 2022

BUY
$2.02 - $3.62 $1.37 Million - $2.46 Million
679,824 Added 232.55%
972,161 $1.96 Million
Q2 2022

Aug 15, 2022

BUY
$3.01 - $4.46 $166,570 - $246,811
55,339 Added 23.35%
292,337 $930,000
Q1 2022

May 16, 2022

BUY
$3.9 - $4.89 $764,232 - $958,229
195,957 Added 477.47%
236,998 $988,000
Q2 2018

Aug 14, 2018

BUY
$13.95 - $20.2 $572,521 - $829,028
41,041 New
41,041 $673,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.27B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.